Academic literature on the topic 'Cytokines; T315I mutation; chronic myeloid leukaemia'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Contents
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cytokines; T315I mutation; chronic myeloid leukaemia.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Cytokines; T315I mutation; chronic myeloid leukaemia"
Asari, Kartini, Susan L. Heatley, Teresa Sadras, Tamara M. Leclercq, Stephen Fitter, Chung Hoow Kok, Andrew C. W. Zannettino, Timothy P. Hughes, and Deborah L. White. "In Vitro Modeling of Ph-like ALL Fusions Identifies Novel Kinase-Domain Mutations As Mode of TKI-Resistance - Implications for Targeted Therapy." Blood 128, no. 22 (December 2, 2016): 3957. http://dx.doi.org/10.1182/blood.v128.22.3957.3957.
Full textHughes, Tim, and Giuseppe Saglio. "Expert Opinion on the Treatment of Refractory Chronic Phase Chronic Myeloid Leukaemia." European Oncology & Haematology 13, no. 01 (2017): 17. http://dx.doi.org/10.17925/eoh.2017.13.01.17.
Full textMassaro, Fulvio, Matteo Molica, and Massimo Breccia. "Ponatinib: A Review of Efficacy and Safety." Current Cancer Drug Targets 18, no. 9 (October 17, 2018): 847–56. http://dx.doi.org/10.2174/1568009617666171002142659.
Full textO’Connor, Lisa M., Stephen Langabeer, Shaun R. McCann, and Eibhlin Conneally. "BCR-ABL Kinase Domain Mutations & SNPs in Imatinib Resistant or Intolerant Chronic Myeloid Leukaemia Patients." Blood 110, no. 11 (November 16, 2007): 2369. http://dx.doi.org/10.1182/blood.v110.11.2369.2369.
Full textJørgensen, H. G., and T. L. Holyoake. "Characterization of cancer stem cells in chronic myeloid leukaemia." Biochemical Society Transactions 35, no. 5 (October 25, 2007): 1347–51. http://dx.doi.org/10.1042/bst0351347.
Full textKhorashad, J. S., N. Thelwell, D. Milojkovic, D. Marin, J. A. Watson, J. M. Goldman, J. F. Apperley, L. Foroni, and A. G. Reid. "A new rapid and sensitive assay for detecting the T315I BCR-ABL kinase domain mutation in chronic myeloid leukaemia." Journal of Clinical Pathology 61, no. 7 (April 22, 2008): 863–65. http://dx.doi.org/10.1136/jcp.2008.056804.
Full textGutierrez, J. Valentin Garcia, Jesùs Odriozola, Javier Lopez, Pilar Herrera, Maria Calbacho, Marta Jimenez-Rolando, Maria Tenorio, Anabelle Chinea, and Jose Garcia-Laraña. "Detection of BCR-ABL Mutations in Patients with Chronic Myeloid Leukemia Treated with Imatinib. Experience of One Centre." Blood 114, no. 22 (November 20, 2009): 4280. http://dx.doi.org/10.1182/blood.v114.22.4280.4280.
Full textVráblová, Lucia, Vladimír Divoký, Pavla Kořalková, Kateřina Machová Poláková, Eva Kriegová, Romana Janská, Jan Grohmann, Milena Holzerová, Tomáš Papajík, and Edgar Faber. "Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia." International Journal of Molecular Sciences 24, no. 3 (January 20, 2023): 2050. http://dx.doi.org/10.3390/ijms24032050.
Full textPelz-Ackermann, Oliver, Michael W. Deininger, Michael Cross, Ines Kovacs, Christine Guenther, Knuth Krohn, Song-Yau Wang, Haifa K. Al-Ali, Dietger W. Niederwieser, and Thoralf Lange. "First Results of a New PCR-Based Approach for a Sensitive and Quantitative Monitoring of BCR-ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia." Blood 108, no. 11 (November 1, 2006): 2191. http://dx.doi.org/10.1182/blood.v108.11.2191.2191.
Full textAbruzzese, Elisabetta, Gabriella Marfe’, Carla Di Stefano, Malgorzata M. Trawinska, Matteo A. Russo, Romano Silvestri, Giovanni Del Poeta, et al. "Pyrrolo[1,2-B][1,2,5] benzodiazepines (PBTDs) Compounds Induce Apoptosis in Chronic Myeloid Leukaemia Cells from Patients at Onset, Imatinib and Second Generation TK Inhibitors (Dasatinib, Nilotinib) Resistant." Blood 108, no. 11 (November 16, 2006): 1385. http://dx.doi.org/10.1182/blood.v108.11.1385.1385.
Full textDissertations / Theses on the topic "Cytokines; T315I mutation; chronic myeloid leukaemia"
Lee, Oi-Lin. "The role of cytokines in governing the expansion of the T315I mutation in chronic myeloid leukaemia." Thesis, 2014. http://hdl.handle.net/2440/95313.
Full textThesis (M.Phil.) -- University of Adelaide, School of Medicine, 2014